For example, we determined that the SORL1 risk factor impinged primarily on AD‐relevant synaptic gene expression, while the ABCA7 variant broadly affected non‐neuronal gene expression, including immune, protein folding, and metabolic pathways. This evidence concerns the gene ABCA7 and Alzheimer disease.